Related Experiment Videos
Elevated serum levels of C-reactive protein in hemodialysis patients
D Docci1, R Bilancioni, A Buscaroli
1Servizio di Nefrologia e Dialisi e, Ospedale M. Bufalini, Cesena, Italy.
Insights
Serum C-reactive protein (CRP) levels are elevated in patients undergoing chronic hemodialysis, unlike those on conservative therapy. This suggests hemodialysis itself may cause the increase, making CRP unreliable as an acute-phase reactant in this context.
Area of Science:
- Nephrology
- Clinical Chemistry
- Immunology
Background:
- Uremia is a complex condition associated with various physiological changes.
- C-reactive protein (CRP) is a marker of inflammation.
- Assessing inflammatory markers in uremic patients is crucial for understanding disease progression and treatment effects.
Purpose of the Study:
- To investigate serum C-reactive protein (CRP) levels in patients with terminal uremia.
- To compare CRP levels between patients on conservative therapy and those on chronic hemodialysis.
- To determine the utility of CRP as an acute-phase reactant in the context of chronic hemodialysis.
Main Methods:
- Serum CRP levels were measured using nephelometry.
- Study included 30 healthy controls, 30 patients with uremia on conservative therapy, and 69 patients on chronic hemodialysis.
- Statistical analysis compared CRP levels and incidence of elevation across groups.
Main Results:
- No significant difference in CRP levels was observed between healthy controls and uremic patients on conservative therapy.
- Both mean CRP concentration and the incidence of elevated CRP levels were significantly higher in patients undergoing chronic hemodialysis compared to controls and conservative therapy groups.
- The elevation in CRP levels showed a direct correlation with the duration of hemodialysis treatment.
Conclusions:
- Chronic hemodialysis itself appears to be associated with elevated serum CRP levels.
- The findings suggest that CRP may not be a reliable acute-phase reactant in patients undergoing chronic hemodialysis due to this dialysis-related abnormality.
- Further investigation is needed to understand the mechanisms behind CRP elevation in hemodialysis patients.
Abstract:
Serum C-reactive protein (CRP) levels were measured by nephelometry in 30 healthy subjects (controls) and in 99 patients with uncomplicated terminal uremia on conservative therapy (group 1, n = 30) or chronic hemodialysis (group 2, n = 69). Whereas there was no difference between controls and group 1, both the mean concentration of CRP and the incidence of elevated levels were significantly higher in group 2 in comparison with both controls and group 1. Moreover, the degree of increase in these patients was directly correlated with the duration of hemodialysis. The abnormality, therefore, is somehow related to chronic hemodialysis per se. From a practical standpoint, we concluded that this test cannot be recommended as an acute-phase reactant in this clinical setting.